Mary E. Rinella
Expertise in
14
conditions

Dr. Mary E. Rinella

Hepatology
355 E. Grand Ave., 
Chicago, IL 
Offers Telehealth
28 Years of Experience
Expertise in
14
conditions
355 E. Grand Ave., 
Chicago, IL 

Overview

Mary Rinella is a Hepatologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 28 years.

Dr. Rinella is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Cirrhosis, Liver Transplant, and Endoscopy.

Dr. Rinella is board certified in Gastroenterology Transplant Hepatology and Practicing Since2002. She is actively involved in clinical research, co-authoring 179 peer reviewed articles and participating in 8 clinical trials.

Residency

University of Chicago Medicine

Specialties

Hepatology

Licenses

Internal Medicine in IL

Board Certifications

Gastroenterology Transplant Hepatology
Practicing Since2002

Fellowships

Northwestern University Hospital

Hospital Affiliations

UChicago Medicine Faculty Physicians

Languages Spoken

English
French
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 13 Less Insurance Carriers -

Locations

UChicago Medicine River East
355 E. Grand Ave., Chicago, IL 60611
Other Locations
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park
5758 S. Maryland Ave., Chicago, IL 60637

Additional Areas of Focus

Dr. Rinella has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Phase 2
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 07, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Enrollment Status: Completed
Publish Date: May 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

179 Total Publications

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.
Journal: Nature reviews. Gastroenterology & hepatology
Published: February 24, 2026
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-4837
Experience:
30+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Laura Kulik is a Hepatologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 30 years. Dr. Kulik is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Liver Embolization. Dr. Kulik is board certified in American Board Of Internal Medicine - Transplant Hepatology (Certified).

Expertise in
16
conditions
Expertise in
16
conditions
Referral required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-4837
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andres Duarte is a Hepatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 25 years. Dr. Duarte is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Duarte is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
23
conditions
Dr. Steven Flamm
Hepatology
Expertise in
23
conditions
Dr. Steven Flamm
Hepatology
Referral may be required

Northwestern Medicine Liver Transplant Care-Aurora

2635 Church Rd, 
Aurora, IL 
 (35.1 miles away)
312-695-4837
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Flamm is a Hepatologist practicing medicine in Aurora, Illinois. Dr. Flamm is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy.

Frequently Asked Questions about Dr. Mary E. Rinella

How do I make an appointment with Dr. Mary E. Rinella?

You can book an appointment with Dr. Mary E. Rinella by calling their office at 888-824-0200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mary E. Rinella a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mary E. Rinella is classified as an Elite expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mary E. Rinella specialize in?

While Dr. Mary E. Rinella is a Hepatology, they have specific expertise in Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Dr. Mary E. Rinella participate in research or clinical trials?

Yes. Dr. Mary E. Rinella has published 179 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Dr. Mary E. Rinella's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mary E. Rinella accept my insurance?

Dr. Mary E. Rinella accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-824-0200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rinella's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile